Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
Titel:
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
Auteur:
Schjesvold, Fredrik H Dimopoulos, Meletios-Athanasios Delimpasi, Sosana Robak, Pawel Coriu, Daniel Legiec, Wojciech Pour, Luděk Špička, Ivan Masszi, Tamas Doronin, Vadim Minarik, Jiri Salogub, Galina Alekseeva, Yulia Lazzaro, Antonio Maisnar, Vladimir Mikala, Gábor Rosiñol, Laura Liberati, Anna Marina Symeonidis, Argiris Moody, Victoria Thuresson, Marcus Byrne, Catriona Harmenberg, Johan Bakker, Nicolaas A Hájek, Roman Mateos, Maria-Victoria Richardson, Paul G Sonneveld, Pieter